CClinicalTrials.gg
CompletedNCT03320291Updated Apr 17, 2019

Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis

An interventional study of Regjoint in Rhizarthrosis, sponsored by Brugmann University Hospital. Completed at 2 sites in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-04-17.

Sponsored by Brugmann University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

In a society based on the use of everyday tools and objects, the loss of function of one or both thumbs due to Rhizarthrosis can drastically reduce the quality of life. Many patients are refractory to preservative treatments.Therefore, multiple arthroplasty techniques were developed.

Trapeziectomy, with or without tendon interposition, gives very good results in terms of pain, function or force. However, it can result in a reduction of the size of the column of the thumb, therefore leading to a loss of force.

Replacement of the trapezo-metacarpal joint with prosthetic material is also proposed and has the advantage to avoid the reduction of the thumb column. Several models are available, mono or bipolar, with a conical or hemispherical cup. Another option is the placement of implants. They were first used when a partial trapeziectomy was possible to counter the collapse of the column and are made of different materials such as metal, silicone, ceramic, pyrocarbon , and gelfoam.

The bioabsorbable poly-LD-lactide implant (PLDLA) is a relatively new possibility for the reconstruction of small joints. Studies have previously revealed that the PLDLA implant is biocompatible and represents a good alternative to arthroplasty by tendon interposition in the reconstruction of the trapezo-metacarpal articulation with osteoarthritis.

In this study, the investigators will investigate the long term effects (1 year after placement) of the Regjoint, a poly-LD-lactide implant (PLDLA).

02

Conditions studied

  • Rhizarthrosis

Browse trials for

Keywords

  • Rhizarthrosis
  • Regjoint
  • Trapeziectomy
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults> 18 years
  • Patients having had a trapeziectomy for more than one year, because of chronic Rhizarthrosis defined by pain and Radiographic Signs, aka articular pinching, bone erosion and potential subluxation of the trapezo-metacarpal joint.

Exclusion criteria

Exclusion Criteria:

  • Surgery less than 1 year ago.
  • Concomitant pathology of the thumb or wrist (Recent injury or trauma, Quervain tenosynovitis, Carpal tunnel syndrome, Dupuytren, jumping finger).
  • Trapeziectomy secondary to distal prosthesis and scaphoidectomy.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Regjoint

    Device: Regjoint

Interventions

  • DeviceRegjoint

    Implant of poly-L / D-lactide (Regjoints®) in the treatment of trapezo-metacarpal osteoarthritis

05

What researchers measure

Primary outcomes

  1. Pain visual assessment scale (EVA scale)

    Pain evaluation in the thumb column by means of the EVA scale. The EVA scale consists of a 10cm graduated strip. The patient must point its pain level on the strip: 0 cm means 'no pain' (one end of the strip) and 10 cm means 'unbearable pain' (other end of the strip).

    Time frame: 1 year post surgery

  2. Quick-DASH questionnaire

    Evaluation of the return to daily life activities (work and sport)

    Time frame: 1 year post surgery

  3. Prehension force

    Measured with a Standard Dynamometer or Hydraulic Pinch Gauge, with the contralateral hand used for comparison.

    Time frame: 1 year post surgery

  4. Maximal amplitude of the articulation

    Measurement of the angle between the axis of the thumb and the index finger, palmar, with a goniometer

    Time frame: 1 year post surgery

  5. Maximal amplitude of the articulation

    Measurement of the angle between the axis of the thumb and the index finger, radial, with a goniometer

    Time frame: 1 year post surgery

  6. Eroded depth

    Evaluation of the bone erosion by means of a radiography (face/profile/oblique). Measure of the degree of subluxation/dislocation.

    Time frame: 1 year post surgery

  7. Kapandji score

    Evaluation of the mobility of the thumb carpal-metacarpal joint

    Time frame: 1 year post surgery

  8. metacarpus length

    Computed by radiography

    Time frame: 1 year post surgery

  9. metacarpal space length

    Computed by radiography

    Time frame: 1 year post surgery

06

Study locations

2 sites
  • CHU Brugmann
    Brussels, 1020, Belgium
  • Clinique du Parc Léopold
    Brussel, 1040, Belgium
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03320291
Lead sponsor
Brugmann University Hospital
Responsible party
Socorro ORTIZ (Head of clinic, Brugmann University Hospital) — Principal investigator
First posted
Oct 25, 2017
Start date
Nov 1, 2017
Primary completion
Oct 10, 2018
Completion
Oct 10, 2018
Last update
Apr 17, 2019

Study contacts

Morgan Gason, MD
principal investigator · CHU Brugmann

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion